These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
485 related items for PubMed ID: 17304257
1. Visual acuity and intraocular pressure after high-dose intravitreal triamcinolone acetonide in selected ocular diseases. Jonas JB, Schlichtenbrede F. Eye (Lond); 2008 Jul; 22(7):869-73. PubMed ID: 17304257 [Abstract] [Full Text] [Related]
2. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Jonas JB. Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641 [Abstract] [Full Text] [Related]
9. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases. Jonas JB, Kreissig I, Degenring R. Prog Retin Eye Res; 2005 Sep; 24(5):587-611. PubMed ID: 16005407 [Abstract] [Full Text] [Related]
10. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion. Goff MJ, Jumper JM, Yang SS, Fu AD, Johnson RN, McDonald HR, Ai E. Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289 [Abstract] [Full Text] [Related]
11. [Macular oedema and intravitreal triamcinolone injections]. Gunnlaugsdóttir E, Oehman DO, Gunnarsdóttir SG, Stefánsson E. Laeknabladid; 2006 Dec; 92(12):847-57. PubMed ID: 17206015 [Abstract] [Full Text] [Related]
12. Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology. Sørensen TL, Haamann P, Villumsen J, Larsen M. Acta Ophthalmol Scand; 2005 Feb; 83(1):67-70. PubMed ID: 15715560 [Abstract] [Full Text] [Related]
13. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases]. Jonas JB, Kreissig I, Kamppeter B, Degenring RF. Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306 [Abstract] [Full Text] [Related]
14. Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide. Jonas JB, Spandau UH, Harder B, Vossmerbaeumer U, Kamppeter BA. Am J Ophthalmol; 2005 Jun; 139(6):1073-9. PubMed ID: 15953439 [Abstract] [Full Text] [Related]